Real-world safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: how risky is fingolimod-induced lymphopenia?

Authors
Publication date
1 September 2019
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Dokuz Eylul University Research Information System

    redirect
    oai450c5f50-937d-4d8f-b7c7-2410a4...
    Last time updated on 20/03/2023